Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8 - PubMed (original) (raw)
Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8
James M Flanagan et al. Genes Chromosomes Cancer. 2004 Jul.
Abstract
Loss of heterozygosity (LOH) on 8p occurs at high frequencies in many tumor types, including colorectal carcinoma (CRC). We previously used microcell-mediated chromosome transfer (MMCT) into the CRC cell line SW620 to map a approximately 7.7-Mb colorectal cancer-suppressor region (CRCSR) at 8p22-23.1. In the current study, we transferred small fragments of this CRCSR into SW620 to refine the region further. Two microcell hybrids containing a 321- to 898-kb region around the D8S552 marker at 8p23.1 showed suppression of soft agar clonicity and tumorigenicity in athymic mice when compared to control cell lines. These data suggest that the putative colorectal tumor-suppressor gene is within this small region. We analyzed two candidate genes within this region: FLJ23749 and KIAA1456. Expression of both genes was detected in normal colonic crypt cells and in mucosa. Quantitative reverse transcriptase polymerase chain reaction showed downregulation of KIAA1456 in 9 of 12 primary colorectal tumors compared to matching normal mucosa, but normal or increased expression of FLJ23749. FLJ23749 was expressed in all CRC cell lines tested; however, KIAA1456 was downregulated in three cell lines, including SW620, and was restored in the suppressed microcell hybrids. 5'aza-2'Deoxycytidine treatment of the downregulated cell lines restored expression of KIAA1456, but bisulfite genomic sequencing did not show a correlation between promoter methylation and expression. Forty percent of the primary tumors showed LOH at this CRCSR locus, and mutation analysis revealed somatic mutations in 1 of 88 primary colorectal tumors for both KIAA1456 and FLJ23749. Despite the rarity of somatic mutations, the expression data suggest that KIAA1456 is still a candidate for the putative 8p colorectal cancer tumor-suppressor gene.
Copyright 2004 Wiley-Liss, Inc.
Similar articles
- Functional evidence for a colorectal cancer tumor suppressor gene at chromosome 8p22-23 by monochromosome transfer.
Gustafson CE, Wilson PJ, Lukeis R, Baker E, Woollatt E, Annab L, Hawke L, Barrett JC, Chenevix-Trench G. Gustafson CE, et al. Cancer Res. 1996 Nov 15;56(22):5238-45. Cancer Res. 1996. PMID: 8912863 - Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma.
Ko JM, Chan PL, Yau WL, Chan HK, Chan KC, Yu ZY, Kwong FM, Miller LD, Liu ET, Yang LC, Lo PH, Stanbridge EJ, Tang JC, Srivastava G, Tsao SW, Law S, Lung ML. Ko JM, et al. Mol Cancer Res. 2008 Apr;6(4):592-603. doi: 10.1158/1541-7786.MCR-07-0154. Mol Cancer Res. 2008. PMID: 18403638 - Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.
Lai J, Flanagan J, Phillips WA, Chenevix-Trench G, Arnold J. Lai J, et al. Br J Cancer. 2003 Jan 27;88(2):270-6. doi: 10.1038/sj.bjc.6600674. Br J Cancer. 2003. PMID: 12610513 Free PMC article. - Mutation analysis of the 8p22 candidate tumor suppressor gene ATIP/MTUS1 in hepatocellular carcinoma.
Di Benedetto M, Pineau P, Nouet S, Berhouet S, Seitz I, Louis S, Dejean A, Couraud PO, Strosberg AD, Stoppa-Lyonnet D, Nahmias C. Di Benedetto M, et al. Mol Cell Endocrinol. 2006 Jun 27;252(1-2):207-15. doi: 10.1016/j.mce.2006.03.014. Epub 2006 May 2. Mol Cell Endocrinol. 2006. PMID: 16650523 Review. - The evidence for human tumor suppressor genes.
Stanbridge EJ. Stanbridge EJ. Princess Takamatsu Symp. 1989;20:3-13. Princess Takamatsu Symp. 1989. PMID: 2577336 Review.
Cited by
- Expanded tRNA methyltransferase family member TRMT9B regulates synaptic growth and function.
Hogan CA, Gratz SJ, Dumouchel JL, Thakur RS, Delgado A, Lentini JM, Madhwani KR, Fu D, O'Connor-Giles KM. Hogan CA, et al. EMBO Rep. 2023 Oct 9;24(10):e56808. doi: 10.15252/embr.202356808. Epub 2023 Aug 29. EMBO Rep. 2023. PMID: 37642556 Free PMC article. - The inhibitory effect of KIAA1456 on the proliferation and metastasis of epithelial ovarian cancer through SSX1 and AKT signaling pathway.
Zhang Y, Sun C, Gao Y, Mao Y, Wu B, Li C, Zhang W, Wang J. Zhang Y, et al. J Cancer. 2023 Mar 27;14(5):770-783. doi: 10.7150/jca.81587. eCollection 2023. J Cancer. 2023. PMID: 37056382 Free PMC article. - Expression of KIAA1456 in lung cancer tissue and its effects on proliferation, migration and invasion of lung cancer cells.
Wang S, Liu X, Huang J, Zhang Y, Sang C, Li T, Yuan J. Wang S, et al. Oncol Lett. 2018 Sep;16(3):3791-3795. doi: 10.3892/ol.2018.9119. Epub 2018 Jul 10. Oncol Lett. 2018. PMID: 30127990 Free PMC article. - Phosphorylation of human TRM9L integrates multiple stress-signaling pathways for tumor growth suppression.
Gu C, Ramos J, Begley U, Dedon PC, Fu D, Begley TJ. Gu C, et al. Sci Adv. 2018 Jul 11;4(7):eaas9184. doi: 10.1126/sciadv.aas9184. eCollection 2018 Jul. Sci Adv. 2018. PMID: 30009260 Free PMC article. - Ovarian cancer proliferation and apoptosis are regulated by human transfer RNA methyltransferase 9-likevia LIN9.
Chen HM, Wang J, Zhang YF, Gao YH. Chen HM, et al. Oncol Lett. 2017 Oct;14(4):4461-4466. doi: 10.3892/ol.2017.6750. Epub 2017 Aug 14. Oncol Lett. 2017. PMID: 29085442 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous